Details of the Drug

General Information of Drug (ID: DME6VDB)

Drug Name

166Ho microspheres

Indication

Disease Entry	ICD 11	Status	REF
Neuroendocrine cancer	2B72.1	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Radiopharmaceutical therapy agent

Cross-matching ID

References

1	ClinicalTrials.gov (NCT02067988) Holmium-166-radioembolization in NET After Lutetium-177-dotatate; an Efficacy Study (HEPAR_Plus). U.S. National Institutes of Health.